PMV Pharmaceuticals Inc (PMVP)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.29+4.03%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PMVP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 64.0 | 69.9 | 58.5 | 55.9 | 52.0 | 36.5 | 23.9 |
| Operating Income | (79.7) | (86.2) | (85.4) | (80.1) | (77.0) | (58.3) | (34.9) |
| Earnings from Continuing Operations | |||||||
| EBT, Incl. Unusual Items | (75.2) | (79.9) | (74.8) | (69.0) | (73.3) | (57.8) | (34.4) |
| Income Tax Expense | — | (2.2) | (16.1) | 0.0 | (0.0) | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (75.2) | (77.7) | (58.7) | (69.0) | (73.3) | (57.8) | (34.4) |
| Per Share | |||||||
| Basic EPS | (1.41) | (1.48) | (1.14) | (1.44) | (1.61) | (1.28) | (2.40) |
| Diluted EPS | (1.41) | (1.48) | (1.14) | (1.44) | (1.61) | (1.28) | (2.40) |
| Basic Weighted Avg Shares | 53.4 | 52.5 | 51.6 | 48.0 | 45.6 | 45.1 | 14.4 |
| Diluted Weighted Avg Shares | 53.4 | 52.5 | 51.6 | 48.0 | 45.6 | 45.1 | 14.4 |
| Supplemental | |||||||
| EBIT | (79.7) | (86.2) | (85.4) | (80.1) | (77.0) | (58.3) | (34.9) |
| Effective Tax Rate | — | — | — | -0.0% | 0.0% | -0.0% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.